CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $67,000 | -18.3% | 33,379 | +10.2% | 0.00% | 0.0% |
Q4 2021 | $82,000 | -32.2% | 30,276 | +11.9% | 0.00% | 0.0% |
Q3 2021 | $121,000 | -22.9% | 27,059 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $157,000 | -8.2% | 26,993 | +10.5% | 0.00% | 0.0% |
Q1 2021 | $171,000 | +47.4% | 24,424 | +0.6% | 0.00% | 0.0% |
Q4 2020 | $116,000 | -21.1% | 24,270 | -3.8% | 0.00% | 0.0% |
Q3 2020 | $147,000 | +15.7% | 25,222 | +33.7% | 0.00% | -50.0% |
Q2 2020 | $127,000 | – | 18,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |